ReviewFrontiers in microbiology2022
Global prevalence, characteristics, and future prospects of IncX3 plasmids: A review.
Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 64 citations in OpenAlex.
- Article
- Spread of carbapenemase-producingEmerging microbes & infections · 2026Article
- Genomic characterization of carbapenem-resistant Gram-negative bacilli isolated from hospital wastewater in Niamey, Niger.IJID regions · 2026Article
- Characteristics of an NDM-1-producing Klebsiella pneumoniae strain belonging to ST105.Antonie van Leeuwenhoek · 2026Article
- Whole-genome sequencing analysis of clinical carbapenemase-producing bacteria isolated in Dakar, Senegal.Microbiology spectrum · 2026Article
- Carbapenemase-Producing Enterobacterales in Pets: A New Threat From Veterinary Clinics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Advancements in Technologies Targeting Horizontal Gene TransferRoutes to Control Drug Resistance Evolution.ACS bio & med chem Au · 2026Review
- Tracing the evolutionary genomics of blaBMC genomics · 2026Article
- Comprehensive genomic analysis of carbapenem-resistant Citrobacter freundii and characterization of a co-carrying blaBMC microbiology · 2026Article
- First Report of KPC-2-Producing Hafnia paralvei: Evidence of Horizontal Gene Transfer fromAnnals of laboratory medicine · 2026Article
- Emergence and dissemination of extensively drug-resistant ST307Microbial genomics · 2026Article
- Mobile Genetic Elements as Central Drivers of Antimicrobial Resistance: Molecular Mechanisms, Evolutionary Ecology, One Health Implications and Control Strategies.Antibiotics (Basel, Switzerland) · 2026Review
- Shifting of blaBMC genomics · 2026Article
- Genomic characteristics of a carbapenem-resistant NDM-1-producingFrontiers in microbiology · 2026Article
- Plasmid-resolved genomics and machine learning-assisted profiling revealFrontiers in microbiology · 2026Article
- Molecular epidemiology and genomic evolution mechanism of carbapenemase-resistantFrontiers in microbiology · 2026Article
- Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026Review
- Rectal Carriage of Sequence Type 307 Klebsiella pneumoniae High-Risk Clone Harboring Multiple Carbapenemase Genes in Community Hospitals Gauteng, South Africa.MicrobiologyOpen · 2025Article
- Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger.Nature communications · 2025Article
- Detection and Genomic Characteristics of NDM-19- and QnrS11-Producing O101:H5Microorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IncX3 plasmids are narrow host range plasmids mostly found in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.